These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 10213569)

  • 1. The UK General Practice Research Database.
    Walley T; Mantgani A
    Lancet; 1997 Oct; 350(9084):1097-9. PubMed ID: 10213569
    [No Abstract]   [Full Text] [Related]  

  • 2. The quantification of drug risks in practice.
    Lee D; Bergman U
    WHO Reg Publ Eur Ser; 1993; 45():79-95. PubMed ID: 8442852
    [No Abstract]   [Full Text] [Related]  

  • 3. Validity of the general practice research database.
    Jick SS; Kaye JA; Vasilakis-Scaramozza C; Garcia Rodríguez LA; Ruigómez A; Meier CR; Schlienger RG; Black C; Jick H
    Pharmacotherapy; 2003 May; 23(5):686-9. PubMed ID: 12741446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of UK clinical databases in enhancing paediatric medication research.
    Wong IC; Murray ML
    Br J Clin Pharmacol; 2005 Jun; 59(6):750-5. PubMed ID: 15948943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A database worth saving.
    Jick H
    Lancet; 1997 Oct; 350(9084):1045-6. PubMed ID: 10213544
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of general practice consultation databases in rheumatology research.
    Jordan K; Porcheret M; Kadam UT; Croft P
    Rheumatology (Oxford); 2006 Feb; 45(2):126-8. PubMed ID: 16368726
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug utilization studies within the VIDEOFAR project.
    Maggini M; Menniti Ippolito F; Spila Alegiani S; Traversa G; Fortini M
    Ann Ist Super Sanita; 1991; 27(2):201-6. PubMed ID: 1755571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project.
    Avillach P; Coloma PM; Gini R; Schuemie M; Mougin F; Dufour JC; Mazzaglia G; Giaquinto C; Fornari C; Herings R; Molokhia M; Pedersen L; Fourrier-Réglat A; Fieschi M; Sturkenboom M; van der Lei J; Pariente A; Trifirò G;
    J Am Med Inform Assoc; 2013 Jan; 20(1):184-92. PubMed ID: 22955495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety.
    Robb MA; Racoosin JA; Sherman RE; Gross TP; Ball R; Reichman ME; Midthun K; Woodcock J
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():9-11. PubMed ID: 22262587
    [No Abstract]   [Full Text] [Related]  

  • 10. The general practice research database: role in pharmacovigilance.
    Wood L; Martinez C
    Drug Saf; 2004; 27(12):871-81. PubMed ID: 15366975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Databases as a source for monitoring systems of drug safety].
    Pigeot I; Ahrens W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):513-7. PubMed ID: 15221098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
    Trifirò G; Coloma PM; Rijnbeek PR; Romio S; Mosseveld B; Weibel D; Bonhoeffer J; Schuemie M; van der Lei J; Sturkenboom M
    J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the recording of 30 common childhood conditions in the Doctor's Independent Network and General Practice Research Databases.
    De Wilde S; Carey IM; Bremner SA; Richards N; Hilton SR; Strachan DP; Cook DG
    Health Stat Q; 2004; (22):21-31. PubMed ID: 15704391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revitalizing the General Practice Research Database: plans, challenges, and opportunities.
    Wood L; Coulson R
    Pharmacoepidemiol Drug Saf; 2001; 10(5):379-83. PubMed ID: 11802580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Record linkage for postmarketing surveillance.
    Faich GA
    Clin Pharmacol Ther; 1989 Oct; 46(4):479-80. PubMed ID: 2791451
    [No Abstract]   [Full Text] [Related]  

  • 17. A primer of drug safety surveillance: an industry perspective. Part III: Managing adverse-event data.
    Allan MC
    J Pharm Technol; 1992; 8(6):259-73. PubMed ID: 10122649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.
    Shapiro S
    Clin Pharmacol Ther; 1989 Oct; 46(4):371-86. PubMed ID: 2535647
    [No Abstract]   [Full Text] [Related]  

  • 19. Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink?
    Leite A; Thomas SL; Andrews NJ
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):25-29. PubMed ID: 29193554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccination and multiple sclerosis: a data mining perspective.
    Hauben M; Sakaguchi M; Patadia V; M Gerrits C
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):943-5. PubMed ID: 17636551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.